Showing 12 of 12 recruiting trials for “Adrenocortical carcinoma”
Study of Preoperative Radiation Therapy in Participants With Resectable Recurrent Abdominal Adrenocortical Carcinoma
A Study of DS9051b in Participants With Advanced or Metastatic Adrenocortical Carcinoma and Metastatic Castration-resistant Prostate Cancer
Phase II Study of PD-1 Antibody Combined With Radiotherapy in Recurrent or Metastatic Adrenal Cortical Carcinoma
RecruitingNCT06279442 ↗
Adrenal Project: Clinical and Epidemiological Characterization of Adrenocortical Carcinoma in a Brazilian Cohort
👨⚕️ Milena Shizue Tariki, Latin American Cooperative Oncology Group📍 10 sites📅 Started Oct 2024View details ↗
Dostarlimab for Locally Advanced or Metastatic Cancer (Non-colorectal/Non-endometrial) With Tumor dMMR/MSI
👨⚕️ Thierry ANDRE, MD, Hôpital Sainte Antoine - Paris - France📍 22 sites📅 Started Jul 2024View details ↗
Study of Radiotherapy and Pembrolizumab in People With Adrenocortical Carcinoma
Pembrolizumab in the Treatment of Advanced, Progressive Adrenocortical Carcinoma.
🏥 Maria Sklodowska-Curie National Research Institute of Oncology📍 4 sites📅 Started Jan 2023View details ↗
Evaluation of the Efficacy of Addition of Progesterone to Standard Chemotherapy in Adrenocortical Carcinoma (ACC)
RecruitingNCT05237934 ↗
Tissue Procurement and Natural History Study of Neuroendocrine Neoplasms (NENs) Including Adrenocortical Carcinoma (ACC)
👨⚕️ Jaydira Del Rivero, M.D., National Cancer Institute (NCI)📍 1 site📅 Started Apr 2022View details ↗
Phase II Study for Combination of Camrelizumab and Apatinib in the Second-line Treatment of Recurrent or Metastatic Adrenocortical Carcinoma
Surgery and Heated Intraperitoneal Chemotherapy for Adrenocortical Carcinoma
RecruitingNCT00453674 ↗
German Adrenocortical Carcinoma Registry
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →